All Allergan articles – Page 2
-
Business
Allergan to buy Kythera Biopharma for $2.1bn
Acquisition strengthens firm’s position in cosmetic treatments with only drug approved for a ‘double chin’
-
-
BusinessActavis rescues Allergan with $66 billion deal
Deal ends takeover fight with Valeant – but Actavis must still be ‘fairly ruthless’ to justify the high price
-
BusinessTakeover battle pushes Allergan to cut R&D jobs
Besieged by serially acquisitive Valeant, the Botox maker will lay off 1500 staff to propel earnings growth
-
BusinessPharma manufacturing woes dog industry
Regulators are stepping up inspections, and discovering ever more problems
-
Business
Allergan buys MAP for $958m
Deal strengthens Allergan’s position in neurology with Levadex for treating migraine
- Previous Page
- Page1
- Page2
- Next Page